(Q47244577)

12 January 2018

title

Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors (English)

1 reference

12 January 2018

1 reference

7

1 reference

12 January 2018

Fabrice Carrat

10

1 reference

12 January 2018

Nathanael Lapidus

object named as

N Lapidus

2

0 references

author name string

F Bani-Sadr

1

1 reference

12 January 2018

J-C Melchior

3

1 reference

12 January 2018

I Ravaux

4

1 reference

12 January 2018

M Bensalem

5

1 reference

12 January 2018

I Rosa

6

1 reference

12 January 2018

S Pol

8

1 reference

12 January 2018

C Perronne

9

1 reference

12 January 2018

publication date

1 April 2008

1 reference

12 January 2018

Journal of Viral Hepatitis

published in

1 reference

12 January 2018

volume

15

1 reference

12 January 2018

issue

4

1 reference

12 January 2018

page(s)

255-260

1 reference

12 January 2018

Side effects of therapy of hepatitis C and their management

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00939.X

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00939.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00939.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00939.X

Incidence and risk factors for weight loss during dual HIV/hepatitis C virus therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00939.X

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00939.X

Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00939.X

Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00939.X

IFN-alpha induces apoptosis of adipose tissue cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00939.X

Weight loss and wasting in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00939.X

Aging, physical activity and height-normalized body composition parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00939.X

Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00939.X

Weight loss in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00939.X

10.1111/J.1365-2893.2007.00939.X

21 January 2018

Identifiers

DOI

1 reference

12 January 2018

1 reference

12 January 2018